Table 1.
Clinical characteristics of study participants stratified by age
| Variable | <52 yr (n=230) | ≥52 yr (n=263) | P-value |
|---|---|---|---|
| Age (year) | 43 ± 6 | 58 ± 5 | <0.001 |
| Male, n (%) | 90 (39.1) | 112 (42.6) | 0.246 |
| Body mass index (kg/m2) | 31 (20–60.8) | 30 (18.8–53.8) | 0.616 |
| Waist circumference (cm) | 101 ± 15 | 102 ± 12 | 0.163 |
| Non-Hispanic White, n(%) | 124 (54) | 200 (76) | <0.001 |
| Treated HTN, n(%) | 40 (17.4) | 87 (33.1) | <0.001 |
| Systolic BP (mmHg) | 121 ± 15 | 126 ± 15 | <0.001 |
| Diastolic BP (mmHg) | 75 ± 10 | 75 ± 9 | 0.995 |
| Pulse pressure (mmHg) | 47 ± 10 | 51 ± 12 | 0.057 |
| Heart rate (/min) | 71 ± 10 | 67 ± 9 | 0.544 |
| NBP/PreHTN/HTN, n (%) | 98/66/66 (42/29/29) | 65/80/118 (25/30/45) | <0.001 |
| SSPG, mg/dL | 161 (41–340) | 164 (43–332) | 0.907 |
| SSPG tertile, n(%) | 79/74/74 (34/33/33) | 85/84/94 (32/32/36) | 0.705 |
| FPG (mg/dL) | 95 (65–123) | 100 (71–126) | <0.001 |
| Total cholesterol (mg/dL) | 186 (116–404) | 194 (113–361) | 0.011 |
| LDL-cholesterol (mg/dL) | 119 ± 34 | 121 ± 33 | 0.359 |
| HDL-cholesterol (mg/dL) | 45 ± 12 | 49 ± 14 | <0.001 |
| Triglycerides (mg/dL) | 107 (32–800) | 118 (29–1217) | 0.453 |
Data are shown as mean±SD, median (range) or as number (%).
NBP: normal blood pressure; PreHTN: prehypertension; SSPG: steady-state plasma glucose; LDL: low density lipoprotein; HDL: high density lipoprotein